STREAMEX CORP. Payments of Stock Issuance Costs
STREAMEX CORP. (STEX) reported Payments of Stock Issuance Costs of $1.07 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2025-04-15
- STREAMEX CORP. payments of stock issuance costs for the quarter ending 2023-09-30 was $237.00K.
- STREAMEX CORP. payments of stock issuance costs for the quarter ending 2023-06-30 was $201.00K, a 54.11% decline year-over-year.
- STREAMEX CORP. payments of stock issuance costs for the quarter ending 2023-03-31 was $482.00K, a 15966.67% increase year-over-year.
- STREAMEX CORP. payments of stock issuance costs for the quarter ending 2022-06-30 was $438.00K.
- STREAMEX CORP. payments of stock issuance costs for fiscal 2023 was $1.07M, a 102.08% increase from fiscal 2022.
- STREAMEX CORP. payments of stock issuance costs for fiscal 2022 was $528.00K, a 46.93% decline from fiscal 2021.
- STREAMEX CORP. payments of stock issuance costs for fiscal 2021 was $995.00K.
- STREAMEX CORP. payments of stock issuance costs for fiscal 2017 was $186.07K, a 62.07% decline from fiscal 2016.
| Period end | Payments of Stock Issuance Costs | Payments of Stock Issuance Costs 1 month | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 3 month as first filed | Payments of Stock Issuance Costs 4 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $1.07M 10-K · filed 2025-04-15 | |||||||
| 2023-09-30 | $237.00K 10-Q · filed 2024-11-14 | $438.00K derived: sum of 2 quarters · filed 2024-11-14 | $920.00K derived: sum of 3 quarters · filed 2024-11-14 | |||||
| 2023-06-30 | $201.00K 10-Q · filed 2024-11-14 | $683.00K derived: sum of 2 quarters · filed 2024-11-14 | ||||||
| 2023-03-31 | $482.00K 10-Q · filed 2024-11-14 | |||||||
| 2022-12-31 | $528.00K 10-K · filed 2024-04-16 | |||||||
| 2022-11-29 | $121.93K 10-K · filed 2023-03-31 | |||||||
| 2022-09-28 | $67.13K 10-Q · filed 2022-11-14 | |||||||
| 2022-06-30 | $438.00K 10-Q · filed 2023-11-14 | $441.00K derived: sum of 2 quarters · filed 2023-11-14 | ||||||
| 2022-06-15 | $46.06K 10-Q · filed 2022-08-15 | |||||||
| 2022-03-31 | $3.00K 10-Q · filed 2023-11-14 | |||||||
| 2021-12-31 | $995.00K 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | $995.00K 10-Q · filed 2021-11-15 | |||||||
| 2021-02-16 | $40.37K 10-K · filed 2023-03-31 | |||||||
| 2020-12-31 | $222.40K 10-K · filed 2022-03-31 | |||||||
| 2020-09-30 | $182.00K 10-Q · filed 2021-11-15 | $182.33B 10-Q · filed 2020-11-05 | $182.33B 10-Q · filed 2020-11-05 | |||||
| 2020-05-20 | $93.42K 10-K · filed 2022-03-31 | |||||||
| 2019-12-31 | $100.00 10-K · filed 2021-03-15 | |||||||
| 2019-03-31 | $1.23K 10-Q · filed 2019-04-15 | |||||||
| 2017-12-31 | $186.07K 10-K · filed 2019-03-15 | |||||||
| 2016-12-31 | $212.35K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $244.81K derived: sum of 2 quarters · filed 2018-02-27 | $467.54K derived: sum of 3 quarters · filed 2018-02-27 | $490.54K 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $32.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $255.19K derived: sum of 2 quarters · filed 2016-11-14 | $278.19K 10-Q · filed 2016-11-14 | |||||
| 2016-06-30 | $222.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $245.73K 10-Q · filed 2016-08-12 | ||||||
| 2016-03-31 | $23.00K 10-Q · filed 2016-05-04 | |||||||
| 2015-12-31 | $608.36K 10-K · filed 2017-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |